Jaseng Hospital of Korean Medicine Demonstrates Efficacy and Safety of Pharmacopuncture for Patients with Lumbar Spinal Stenosis
A Year-long Follow-up Study of 98 Patients with Lumbar Spinal Stenosis
Randomized into Pharmacopuncture and Conventional Treatment Groups
A study has found that pharmacopuncture treatment for patients with lumbar spinal stenosis reduces pain and significantly restores daily functioning compared to conventional treatments such as physical therapy and analgesics.
The research team led by Director Lee Suwon at the Jaseng Spine and Joint Research Institute announced on June 9 that their findings, which demonstrate the clinical efficacy and safety of pharmacopuncture for patients with lumbar spinal stenosis, have been published in the SCI(E)-indexed international journal "Integrative Medicine Research" (IF=3.0).
Medical staff at Jaseng Hospital of Korean Medicine are administering pharmacopuncture treatment to a patient with lumbar spinal canal stenosis. Jaseng Hospital of Korean Medicine
View original imageLumbar spinal stenosis is a degenerative disease in which the nerve and vascular structures of the spinal canal are gradually compressed due to degenerative changes, causing lower back pain, radiating pain in the legs, and intermittent neurogenic claudication. It is estimated that about 103 million people worldwide are affected. As societies age and diagnostic technology advances, the number of patients continues to rise. According to the Health Insurance Review & Assessment Service, the number of patients in Korea with spinal stenosis increased by approximately 12%, from 1,659,452 in 2020 to 1,856,224 in 2024.
Conservative treatments such as physical therapy and medication are initially used for lumbar spinal stenosis, but surgical treatment may be considered if symptoms persist or worsen. However, surgery carries risks including complications such as dural injury and hematoma, as well as the possibility of failed back surgery syndrome, where pain continues after surgery. These risks must be carefully considered, especially in older patients, who also face a higher burden of delayed recovery and complications following surgery.
For these reasons, many patients prefer conservative treatments and may choose integrative Korean medicine therapies, which are widely known for their safety. In clinical practice, acupuncture is often combined with pharmacopuncture. Pharmacopuncture involves injecting refined, extracted, and sterilized herbal extracts directly into acupuncture points or targeted areas. This method rapidly suppresses inflammation, relieves pain, and promotes tissue recovery. Though there have been clinical studies on the effects of pharmacopuncture for chronic low back pain, there have been no randomized controlled trials (RCTs) comparing pharmacopuncture as a stand-alone treatment group specifically for patients with lumbar spinal stenosis.
Against this background, the research team led by Director Lee Suwon at the Jaseng Spine and Joint Research Institute conducted a study involving patients diagnosed with lumbar spinal stenosis through radiological examinations at four branches of Jaseng Hospital of Korean Medicine (Gangnam, Daejeon, Bucheon, Haeundae), Kyung Hee University Korean Medicine Hospital, Kyung Hee University Gangdong Korean Medicine Hospital, and Dongguk University Bundang Korean Medicine Hospital.
The researchers randomly assigned 98 patients aged 19 to 69 years, all of whom had neurogenic claudication and lower back or leg pain (measured by the Numeric Rating Scale [NRS], 0–10), to either the pharmacopuncture group or the conventional treatment group (physical therapy and analgesics) in a 1:1 ratio. The pharmacopuncture group received pharmacopuncture treatment twice a week for 12 weeks, while the conventional treatment group received physical therapy and analgesics as needed over the same period. Patients were then followed up to week 53.
The results showed that at week 13, after completing treatment, the pharmacopuncture group reported a reduction in their dominant pain (either low back pain or radiating leg pain, whichever was worse) that was 2.7 points greater than that of the conventional treatment group. When analyzing low back pain and leg pain separately, the pharmacopuncture group’s NRS scores were 2.8 points lower for low back pain and 2.9 points lower for leg pain compared to the conventional treatment group. This effect was maintained through week 53.
Similar results were observed in measures of functional improvement. On all assessment tools—including the Zurich Claudication Questionnaire (ZCQ), a dedicated and internationally used instrument for spinal stenosis, and the Oswestry Disability Index (ODI; 0–50)—the pharmacopuncture group showed significantly greater improvement than the conventional treatment group.
Specifically, on the ZCQ, the pharmacopuncture group demonstrated better improvements in both symptom and functional domains than the conventional group. The degree of symptom improvement was comparable to the level experienced by patients one year after spinal stenosis surgery.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The Oswestry Disability Index (ODI) scores also showed clear improvement. Compared to the moderate improvement criteria (MCID) for clinically meaningful improvement in non-surgical lumbar spinal stenosis patients, the pharmacopuncture group’s ODI decreased by more than the MCID after treatment. By week 53, the difference between the two groups neared 16 points, indicating a level of functional recovery that patients could perceive in their daily lives.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.